title: Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model.
authors.affiliation: Department of Pharmacology, Victor Segalen Bordeaux University, Bordeaux, France.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Lagrange
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Brun
authors.forename: Marie Christine
authors.initials: MC
authors.lastname: Vergnes
authors.forename: Francis
authors.initials: F
authors.lastname: Paolucci
authors.forename: Teresa
authors.initials: T
authors.lastname: Nadal
authors.forename: Jean-Joel
authors.initials: JJ
authors.lastname: Leng
authors.forename: Marie Claude
authors.initials: MC
authors.lastname: Saux
authors.forename: Bernard
authors.initials: B
authors.lastname: Bannwarth
mesh_terms: D000328:Adult; D017984:Enoxaparin / Q000493:pharmacokinetics*; D065427:Factor Xa Inhibitors; D005260:Female; D005343:Fibrinolytic Agents / Q000493:pharmacokinetics*; D000077425:Fondaparinux; D006801:Humans; D066298:In Vitro Techniques; D008431:Maternal-Fetal Exchange; D008954:Models, Biological; D010920:Placenta / Q000098:blood supply*; D011134:Polysaccharides / Q000493:pharmacokinetics*; D011247:Pregnancy
chemical_list: D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux